An interventional study of Portion control and Healthy lifestyle in Lifestyle Intervention, Weight Management and Behaviour Change, sponsored by Clinica Universidad de Navarra, Universidad de Navarra. Recruiting at 1 site in Spain. Open to participants aged 18 Years to 70 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-12.
Sponsored by Clinica Universidad de Navarra, Universidad de Navarra · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
This is a 12-month randomized controlled trial designed to evaluate the effectiveness of a comprehensive self-applied lifestlye intervention for weight loss, based on portion control. A total of 181 volunteers with overweight/obesity will be randomly allocated to an experimental intervention group or an active control group. The experimental intervention will include 4 components: (1) a portion control toolset (eating utensils); (2) a manual including instructions for the use of the tools, dietary and activity recommendations, and behavioural strategies; (3) a mobile app to motivate intervention engagement; and (4) a recipe book to help integrate the intervention in daily life. The control group will receive standard guidelines for healthy living, including diet and physical activity. Both groups will attend 4 clinical investigation days, 2 group sessions and will receive periodic telephone support. The primary outcome will be the change in waist circumference from baseline, assessed at 3, 9 and 12 months. Other measurements will include body composition, fasting biochemical parameters, eating behaviour, gut microbiota, functional magnetic resonance, portion size norms, intervention adherence and acceptance. The study will test the hypothesis that a comprehensive intervention focused on portion control can promote changes in eating habits and reduce waist circumference over 12 months compared with receving standard healthy living advice (active control group).
Overweight and obesity are highly prevalent worldwide and represent major public health challenges. Nutritional interventions aimed at weight management frequently require sustained changes in eating behaviour, yet maintaining adherence to dietary recommendations over the long term remains challenging. Portion control represents a potentially useful strategy for promoting healthier eating habits, particularly through its potential effects on dietary energy density and meal composition. However, the mechanisms through which sustained changes in portion-related behaviours may influence body composition, metabolic health, eating behaviour and other physiological and cognitive processes remain insufficiently understood. Another challenge in nutritional intervention research is to assess dietary changes beyond their relationship with body weight alone. Changes in eating behaviour may be associated with metabolic markers, cognitive and behavioural processes, neural responses related to food intake, gut microbiota, and quality of life. A comprehensive assessment of these dimensions may therefore contribute to a better understanding of the factors associated with adherence to nutritional interventions and successful long-term weight management.
The primary objective of this randomized controlled trial is to confirm the effectiveness and long-term impact of a comprehensive weight management intervention focused on changing eating habits through portion control. The intervention is designed to facilitate the self-management of eating behaviour and promote sustained changes in the selection, composition and quantity of food consumed. The effect of the intervention will be assessed through changes in body composition at 3, 9 and 12 months, with change in waist circumference as the primary outcome. Secondary assessments will include metabolic, cognitive-behavioural and quality of life measures. The selection of these variables is informed by findings from the preceding PORTIONS-4 pilot study and by the scientific literature supporting the assessment of anthropometric and functional measures of adiposity in addition to weight and height-based indices such as body mass index (BMI), as well as comprehensive assessment of cognitive and behavioural factors, including habit formation, involved in eating and adherence.
The study will use a two-arm randomized controlled trial design, with participants allocated to either an experimental intervention group or a control group. A total of 181 participants will be enrolled, with 121 participants assigned to the experimental group and 60 to the control group. Participants allocated to the experimental group will receive a set of theoretical and practical strategies specifically developed or selected for this study to facilitate self-management of health and, in particular, the consumption of foods in recommended portions and quantities. The experimental intervention will consist of 4 complementary components: (1) an educational guide providing recommendations on nutrition, well-being and physical activity; (2) a toolset of optimized dietary tools consisting of a portion-serving spoon and a calibrated oil dispenser; (3) a recipe book specifically designed to provide healthy and sustainable recipes consistent with the intervention principles; and (4) a mobile application designed to support engagement with the intervention and facilitate the implementation of its recommendations in daily life. Participants allocated to the control group will receive an enhanced standard intervention based on theoretical nutrition education derived from recommendations provided by official health and nutrition organizations, together with recipes and physical activity guidelines. Both groups will participate in the intervention for 12 months, will receive six follow-up telephone calls throughout the intervention period and will receive the same degree of training and follow-up support, in order to minimize the potential influence of differences in contact level, education or support between groups.
The protocol includes clinical assessments at baseline and at 3, 9 and 12 months. Participants will also take part in two initial group sessions, two final group sessions and one central focus group (subsample) during the intervention period. At the scheduled clinical assessments, participants will undergo a comprehensive evaluation including biochemical measurements (glucose, insulin, lipid profile, ghrelin and glucagon-like peptide-1), body composition (assessed by bioelectrical impedance analysis) and physical function (handgrip strength assessment), psychological and quality-of-life questionnaires, eating rate and dietary composition. The study will also assess habit formation, food addiction, sensory and behavioural characteristics potentially related to eating behaviour, including taste detection thresholds. Changes in the gut microbiome will be evaluated to investigate potential biological adaptations associated with the intervention. In addition, functional magnetic resonance imaging will be used in a subsample to assess changes in neural activation and connectivity within networks involved in food-related processing and eating behaviour. These assessments will contribute to the investigation of potential interactions between eating behaviour, the gut microbiome and brain function during the weight management process.
The overall aim of these complementary assessments is to identify physiological, behavioural and cognitive mechanisms associated with adherence to and success of nutritional interventions for weight management. Understanding these mechanisms may contribute to the development of more personalized, effective and sustainable approaches to nutritional intervention. The primary hypothesis is that, compared with the control group, participants receiving the experimental intervention will show greater improvements in waist circumference and other measures of body composition over the 12-month intervention period. Improvements are also expected in BMI and fat mass. It is further hypothesized that participants in the experimental group will show greater improvements in dietary composition and in their ability to identify and apply appropriate portion sizes, reflected in healthier food choices and greater use of the portion-control strategies provided by the intervention. These effects are expected to be associated with greater utilization and adherence to the experimental intervention components. Compared with the control group, the experimental group is also expected to show more favourable changes in metabolic markers, cognitive and behavioural measures, and quality-of-life questionnaire scores over time. Finally, the study is expected to identify differences between groups in gut microbiota patterns and neural activation or connectivity associated with eating behaviour. Together, these findings may help clarify the physiological and cognitive mechanisms underlying adherence and response to comprehensive nutritional interventions for weight management.
Clinica Universidad de Navarra, Universidad de Navarra is the lead sponsor of 161 studies on the registry; 37 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
ADDITIONAL EXCLUSION CRITERIA FOR SUB-STUDIES
Functional MRI sub-study - Additional Exclusion Criteria:
Gut microbiota sub-study - Additional Exclusion Criteria
During the 15 days preceding stool sample collection:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
A planned gap after a treatment, so that its effects can lessen before the study treatment or a study assessment. Ask the study team and the doctor who prescribed it before changing any medicine.
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
BMI (body mass index)
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Washout period
A planned gap after a treatment, so that its effects can lessen before the study treatment or a study assessment. Ask the study team and the doctor who prescribed it before changing any medicine.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Contraindication
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Participants will receive a comprehensive 12-month intervention focused on changing eating habits through portion control. The intervention will include four components to promote lifestyle modification: (1) an educational guide with recommendations on nutrition, well-being and physical activity; (2) a portion-control toolset (calibrated oil dispenser and portion control serving spoon); (3) a healthy and sustainable recipe book; and (4) a mobile application to foster engagement with the intervention. Participants will also receive 6 follow-up telephone calls during the intervention period and will attend 4 clinical investigation days and 2 group sessions (with an additional 2 optional group sessions). A subsample of participants will undergo a focus group session (n=30) or functional magnetic resonance imaging (n=20).
Behavioral: Portion control
Participants will receive a 12-month enhanced standard intervention based on printed nutrition and physical activity recommendations/guidelines from official health and nutrition organizations (i.e., WHO). The intervention will include general dietary advice, recipes and physical activity guidelines. Participants will also receive 6 follow-up telephone calls during the intervention period and will attend 4 clinical investigation days and 2 group sessions (with an additional 2 optional group sessions). A subsample of participants will undergo a focus group session (n=15) or functional magnetic resonance imaging (n=10).
Behavioral: Healthy lifestyle
Self-applied, multicomponent intervention with a previously validated portion control toolset
Also known as: Lifestyle modification, Behaviour change
Active comparator with same level of follow-up as experimental group
Also known as: Behaviour change
Change in Waist Circumference From Baseline
Change in waist circumference (cm) from baseline will be assessed over the 12-month intervention period. Waist circumference will be measured using standardized anthropometric procedures
Time frame: Week -1, Week 0, Week 12, Week 36, Week 48
Change from baseline in dietary energy density (kcal/g)
Dietary energy (in kcal) and Dietary volume (in g) will be combined to obtain Dietary energy density (kcal/g).
Time frame: Week -1, Week 4, Week 8, Week 12, Week 16, Week 20, Week 24, Week 28, Week 32, Week 36, Week 40, Week 44, Week 48
Change from baseline in dietary nutrient composition (in g)
Dietary nutrient composition (in g) will be defined as the average % energy provided by macronutrients, obtained from the 24 h dietary record
Time frame: Week -1, Week 4, Week 8, Week 12, Week 16, Week 20, Week 24, Week 28, Week 32, Week 36, Week 40, Week 44, Week 48
Change from baseline in dietary nutrient composition (in % energy)
Dietary nutrient composition (in % energy) will be defined as the average % energy provided by macronutrients, obtained from the 24 h dietary record
Time frame: Week -1, Week 4, Week 8, Week 12, Week 16, Week 20, Week 24, Week 28, Week 32, Week 36, Week 40, Week 44, Week 48
Use of serving spoon (24 h frequency)
Number of times the intervention spoon has been used in a period of 24 h (experimental arm only)
Time frame: Week 4, Week 8, Week 12, Week 16, Week 20, Week 24, Week 28, Week 32, Week 36, Week 40, Week 44, Week 48
Use of oil dispenser (24 h frequency)
Number of times the oil dispenser has been used in a period of 24 h (experimental arm only)
Time frame: Week 4, Week 8, Week 12, Week 16, Week 20, Week 24, Week 28, Week 32, Week 36, Week 40, Week 44, Week 48
Use of intervention guide (24 h frequency)
Number of times the intervention guide has been used in a period of 24 h
Time frame: Week 4, Week 8, Week 12, Week 16, Week 20, Week 24, Week 28, Week 32, Week 36, Week 40, Week 44, Week 48
Use of intervention app (24 h frequency)
Number of times the intervention app has been used in a period of 24 h (experimental arm only)
Time frame: Week 4, Week 8, Week 12, Week 16, Week 20, Week 24, Week 28, Week 32, Week 36, Week 40, Week 44, Week 48
Use of cookbook (24 h frequency)
Number of times the cookbook has been used in a period of 24 h
Time frame: Week 4, Week 8, Week 12, Week 16, Week 20, Week 24, Week 28, Week 32, Week 36, Week 40, Week 44, Week 48
Use of serving spoon (15 day frequency)
Number of times the intervention spoon has been used in a period of 15 days (experimental arm only)
Time frame: Week 4, Week 8, Week 12, Week 16, Week 20, Week 24, Week 28, Week 32, Week 36, Week 40, Week 44, Week 48
Use of oil dispenser (15 day frequency)
Number of times the oil dispenser has been used in a period of 15 days (experimental arm only)
Time frame: Week 4, Week 8, Week 12, Week 16, Week 20, Week 24, Week 28, Week 32, Week 36, Week 40, Week 44, Week 48
Use of intervention guide (15 day frequency)
Number of times the intervention guide has been used in a period of 15 days
Time frame: Week 4, Week 8, Week 12, Week 16, Week 20, Week 24, Week 28, Week 32, Week 36, Week 40, Week 44, Week 48
Use of intervention app (15 day frequency)
Number of times the intervention app has been used in a period of 15 days (experimental arm only)
Time frame: Week 4, Week 8, Week 12, Week 16, Week 20, Week 24, Week 28, Week 32, Week 36, Week 40, Week 44, Week 48
Use of cookbook (15 day frequency)
Number of times the cookbook has been used in a period of 15 days
Time frame: Week 4, Week 8, Week 12, Week 16, Week 20, Week 24, Week 28, Week 32, Week 36, Week 40, Week 44, Week 48
Anthropometric profile: Body Height
Height will be measured in m using a stadiometer
Time frame: Week -1
Anthropometric profile: Body Weight
Weight will be measured in kg using Tanita scales
Time frame: Week -1, Week 0
Anthropometric profile: Waist Circumference
Waist circumference will be measured in cm using a measuring tape
Time frame: Week -1
Anthropometric profile: Hip Circumference
Hip circumference will be measured in cm using a measuring tape
Time frame: Week -1
Anthropometric profile: Neck Circumference
Neck circumference will be measured in cm using a measuring tape
Time frame: Week -1
Anthropometric profile: Change from baseline in Body Weight
Weight will be measured in kg
Time frame: Week 12, Week 36, Week 48
Anthropometric profile: Change from baseline in Body Mass Index
Body Mass Index will be calculated from weight and height as kg/m\^2
Time frame: Week 12, Week 36, Week 48
Anthropometric profile: Change from baseline in Waist to Hip Ratio
Waist to hip ratio is defined as the ratio of the waist circumference (cm) to the hip circumference (cm)
Time frame: Week 12, Week 36, Week 48
Anthropometric profile: Change from baseline in body fat composition
Body fat composition will be quantified as fat mass (in kg, %) from a body composition analyser
Time frame: Week 0, Week 12, Week 36, Week 48
Biochemical profile: Change from baseline in fasting blood glucose
Fasting blood glucose levels (mg/dL)
Time frame: Week 0, Week 12, Week 36, Week 48
Biochemical profile: Change from baseline in fasting insulin
Fasting blood insulin levels (mIU/L)
Time frame: Week 0, Week 12, Week 36, Week 48
Biochemical profile: Change from baseline in fasting blood triglycerides
Fasting blood triglycerides levels (mg/dL)
Time frame: Week 0, Week 12, Week 36, Week 48
Biochemical profile: Change from baseline in fasting blood total cholesterol
Fasting blood total cholesterol levels (mg/dL)
Time frame: Week 0, Week 12, Week 36, Week 48
Biochemical profile: Change from baseline in fasting blood HDL-cholesterol
Fasting blood HDL-cholesterol levels (mg/dL)
Time frame: Week 0, Week 12, Week 36, Week 48
Biochemical profile: Change from baseline in fasting blood LDL-cholesterol
Fasting blood LDL- cholesterol levels (mg/dL)
Time frame: Week 0, Week 12, Week 36, Week 48
Biochemical profile: Change from baseline in fasting blood ghrelin
Fasting blood ghrelin levels (pg/mL)
Time frame: Week 0, Week 12, Week 36, Week 48
Biochemical profile: Change from baseline in fasting blood leptin
Fasting blood leptin levels (ng/mL)
Time frame: Week 0, Week 12, Week 36, Week 48
Biochemical profile: Change from baseline in fasting blood GLP-1
Fasting blood GLP-1 levels (pmol/mL)
Time frame: Week 0, Week 12, Week 36, Week 48
Meal eating behaviour: Change from baseline in Eating rate
Average amount of yogurt with granola consumed per unit of time (g/min), based on validated methodology (Yeomans, 2000)
Time frame: Week 0, Week 12, Week 36, Week 48
Meal eating behaviour: Change from baseline in Bite Size
Average amount of yogurt with granola consumed at each bite (g), based on validated methodology (Yeomans, 2000)
Time frame: Week 0, Week 12, Week 36, Week 48
Meal eating behaviour: Change from baseline in Meal Duration
Average time used to eat a yogurt with granola (min), based on validated methodology (Yeomans, 2000)
Time frame: Week 0, Week 12, Week 36, Week 48
Meal eating behaviour: Change from baseline in Deceleration Rate
Average change in eating rate (g/sec-squared), based on validated methodology (Yeomans, 2000)
Time frame: Week 0, Week 12, Week 36, Week 48
Learning task: Change from baseline in learned meal portion size
% error in chosen portion sizes for starch, protein and vegetables of a virtual meal vs recommended portion sizes (based on Brunstrom \& Rogers, 2009)
Time frame: Week 0, Week 12, Week 36, Week 48
Learning task: Change from baseline in learned meal nutrient content
% error in chosen nutrient content of a virtual meal vs recommended nutrient content (based on Brunstrom \& Rogers, 2009)
Time frame: Week 0, Week 12, Week 36, Week 48
Neural Activity Related to Food Reward Processing
Neural activity associated with food reward and eating- related sensations, assessed using functional magnetic resonance imaging (fMRI) during exposure to food-related auditory stimuli, based on Carnell et al., 2017 (Subsample n=30 only)
Time frame: Week 0, Week 24, Week 48
Gut Microbiota Diversity and Bacterial Abundance
Gut microbiota diversity and abundance of bacterial taxa associated with metabolic status, adiposity, mental health, and eating behavior
Time frame: Week 0, Week 48
Food addiction
Food addiction symptoms assessed using the Yale Food Addiction Scale (YFAS), validated by Granero et al., 2018
Time frame: Week -1, Week 24, Week 48
Habit Automaticity
Automaticity of eating-related habits assessed using the Self-Report Behavioural Automaticity Index (SRBAI), validated by Gardner et al., 2012
Time frame: Week 1, Week 4, Week 8, Week 12, Week 16, Week 20, Week 24, Week 28, Week 32, Week 36, Week 40, Week 44, Week 48
Eating habits: Eating profile
Individual profile defined by the combined Restraint (0-21 points), Disihnibition (0-16 points) and Susceptibilty to hunger (0-14 points) sub-scales scores of the Three Factor Eating Questionnaire (TFEQ), validated by Stunkard \& Messick, 1985. Restraint values above 11, disinhibition values above 8 and susceptibility to hunger values above 4 are considered worse outcomes (i.e. risk for development of obesity and other eating disorders)
Time frame: Week 0, Week 12, Week 36, Week 48
Dietary energy (kcal)
Dietary energy (kcal) will be obtained from the 24 h dietary record
Time frame: Week -1, Week 4, Week 8, Week 12, Week 16, Week 20, Week 24, Week 28, Week 32, Week 36, Week 40, Week 44, Week 48
Dietary volume (in g)
Dietary volume (g) will be obtained from the 24 h dietary record
Time frame: Week -1, Week 4, Week 8, Week 12, Week 16, Week 20, Week 24, Week 28, Week 32, Week 36, Week 40, Week 44, Week 48
Handgrip strength
Handgrip strength will be measured in kg using a dynamometer
Time frame: Week 0, Week 12, Week 36, Week 48
Eating habits: Risk of eating disorders
Score in the Eating Attitudes Test-26 (EAT-26), ranging from 0-78 points, validated by Garner et al., 1982. Scores above 20 suggest a higher risk for presence of potential eating disorders
Time frame: Week -1
Physical activity level
Score in the short-form International Physical Activity Questionnaire (IPAQ), expressed as metabolic equivalent of task (MET)-minutes per week (Craig et al., 2003). Higher MET minutes indicates higher levels of physical activity.
Time frame: Week 0, Week 12, Week 36, Week 48
Quality of Life (QoL)
Score in the World Health Organization Quality of Life-BREF (WHOQOL-BREF) questionnaire (The WHOQOL Group, 1998). Higher scores indicate a higher perception of quality of life.
Time frame: Week 0, Week 12, Week 36, Week 48
Eating habits: Frequency of homemade meals
Frequency of consuming homemade meals via self-reported questionnaire
Time frame: Week -1
Eating habits: Frequency of take away meals
Frequency of consuming take away meals via self-reported questionnaire
Time frame: Week -1
Eating habits: Meal prep and serving
Responsible person for cooking at home, via self-reported questionnaire
Time frame: Week -1
Eating habits: Liking for the intervention food (yogurt with granola)
Liking for the foods to be used in the intervention, via self-reported questionnaire (100 mm visual analogue scale)
Time frame: Week -1, Week 0, Week 12, Week 36, Week 48
Eating habits: Familiarity with the intervention food (yogurt with granola)
Familiarity with the foods to be used in the intervention, via self-reported questionnaire (100 mm visual analogue scale)
Time frame: Week 0, Week 12, Week 36, Week 48
Eating habits: Beverage consumption habits
Shortened version of the pre-piloted on-line Beverage Portion Size survey (Self-reported questionnaire assessing caloric beverage intake and awareness of beverage portion sizes) (Vargas-Alvarez et al., 2022)
Time frame: Week 0
Eating habits: Problem Eating Behaviour Questionnaire (PEBQ)
Validated questionnaire (Carter \& Jansen, 2012) used to identify eating patterns associated with the risk for obesity. It consists of 25 items answered on a 5-Pt intensity scale. The information collected can be used qualitatively, to identify problematic behaviors, or quantitatively by adding the direct scores. Scores greater than 50 suggest a moderate to high frequency of behaviors associated with obesity
Time frame: Week 0, Week 12, Week 36, Week 48
Self-reported medical history
Self-reported questionnaire based on previous studies (Almiron-Roig et al., 2023) asking about special dietary needs, pregnancy, lactation, menopause, history of eating disorders, history of mental illness, incompatible medical conditions (e.g., cancer, diabetes, memory loss), regular medication including nutritional and other supplements
Time frame: Week -1
Anthropometric profile: General body composition
Fat mass distribution (trunk, arms, legs), fat-free mass (kg, %), fat-free mass distribution, visceral fat score, basal metabolic rate (kcal/day)
Time frame: Week 0, Week 12, Week 36, Week 48
Psychological profile: Personality
Score in the NEO-Five Factor Inventory (NEO-FFI) 60 item validated questionnaire (Costa \& McCrae, 1989). The score for each central domain of normal personality defined by the Five-Factor Model of personality (neuroticism, extraversion, conscientiousness, agreeableness, and openness to experience) is calculated. A higher score on a scale assessing a certain personality domain indicates a stronger expression of traits associated with this particular domain
Time frame: Week -1
Psychological profile: Perceived stress
Score in the Perceived Stress Scale-14 (PSS-14) validated questionnaire (Cohen et al., 1983). Scores ranging from 0 to 13 suggest low stress, scores ranging from 14 to 24 suggest moderate stress, and scores above 27 suggest high perceived stress
Time frame: Week -1
Psychological profile: Emotional intelligence
Score in the Trait Meta-Mood Scale-24 (TMMS-24) validated questionnaire (Salovey et al., 1995). The score for three different dimensions of emotional intelligence are calculated. To obtain a score for each factor, items 1 to 8 are added for the emotional attention factor, items 9 to 16 for the emotional clarity factor, and items 17 to 24 for the emotional repair factor
Time frame: Week -1
Psychological profile: Mood
Score in the Profile of Mood States (POMS) validated questionnaire (McNair et al., 1971). The score for six different dimensions of mood (tension, anger, fatigue, depression, confusion, and vigour) is calculated. A higher score on a scale assessing a certain mood dimension indicates a stronger expression of associated feelings. The resulting scores will range from -24 to 177, with lower scores indicative of people with more stable mood profiles
Time frame: Week -1
Attitude towards intervention: Intervention expectations
Self-constructed scale evaluated with the sum of scores (1-10) for 5 items (based on Borkovec \& Nau, 1972). The 5 items include rating the intervention's logic, satisfaction, recommendability, expected usefulness, and the respondent's readiness to follow it. A higher score reflects a more positive expectation towards the upcoming intervention
Time frame: Week 0
Attitude towards intervention: Intervention opinion
Self-constructed scale evaluated with the sum of scores (1-10) for 5 items (based on Nau \& Borkovec, 1972). The 5 items include rating the intervention's logic, satisfaction, recommendability, usefulness, and the respondent's readiness/intention to continue with it. A higher score reflects a more positive opinion towards the experienced intervention
Time frame: Week 12, Week 36
Attitude towards intervention: Dietetic tool acceptance (serving spoon, oil dispenser)
Previously piloted questionnaire (Almiron-Roig et al., 2016) including 5-Pt Likert scores for portion tool attractiveness, fits within lifestyle, embarrassment, ease of use, perceived effectiveness and resistant to use. An average score of 1 or 2 indicates low acceptance, 3 neutral, and 4 or 5 high acceptance (experimental arm only)
Time frame: Week 12, Week 36, Week 48
Attitude towards intervention: Dietetic tool intention to use (serving spoon, oil dispenser)
Single scale instrument measuring the level of intention to use each component from 0-100 on a 100 mm visual analogue scale (previously piloted questionnaire, Almiron-Roig et al., 2016) (experimental arm only)
Time frame: Week 12, Week 36, Week 48
Attitude towards intervention: Perceived app usability
System Usability Scale (SUS) (based on Brooke, 1996). Includes ten 5-Pt Likert questions of which 5 items are scored positively (pleasant, easy to use, good functionality, quick to learn, safe), and 5 items are scored reversedly (complex, requires support, inconsistent, complicated to use, requires learning). A higher overall score indicates higher perceived usability (experimental arm only)
Time frame: Week 12, Week 36, Week 48
Attitude towards intervention: App intention to use
Single scale instrument measuring the level of intention to use the intervention app from 0-100 on a 100 mm visual analogue scale (previously piloted questionnaire, Almiron-Roig et al., 2016) (experimental arm only)
Time frame: Week 12, Week 36, Week 48
Attitude towards intervention: Intervention guide assessment
Self-constructed questionnaire including 20 items answered with a 5-Pt Likert scale. The first 10 items assess content of the guide (credibility, coherence, usefulness, applicability) and the second 10 items assess format (organisation, word choice and communication style). A score \<60 indicates poor assessment (the tool cannot be used in clinical practice as it stands); a score between 60-79 indicates the tool needs revision before implementation; a score of 80 or above indicates the tool is well rated by potential users and may be useful in clinical practice
Time frame: Week 12
Attitude towards intervention: Intervention guide intention to use
Single scale instrument measuring the level of intention to use the intervention guide from 0-100 on a 100 mm visual analogue scale (previously piloted questionnaire, Almiron-Roig et al., 2016)
Time frame: Week 12
Attitude towards intervention: Cookbook assessment
Self-constructed questionnaire including 6 items answered with a 5-Pt Likert scale. The items assess coherence, usefulness, applicability, contents, word choice and communication style. A score \<18 indicates poor assessment (the tool cannot be used in clinical practice as it stands); a score between 18-24 indicates the tool needs revision before implementation; a score of 24 or above indicates the tool is well rated by potential users and may be useful in clinical practice
Time frame: Week 12
Attitude towards intervention: Cookbook intention to use
Single scale instrument measuring the level of intention to use the Cookbook from 0-100 on a 100 mm visual analogue scale (previously piloted questionnaire, Almiron-Roig et al., 2016)
Time frame: Week 12
Intervention component usage: serving spoon
Monthly questionnaire asking about types of meals in which the serving spoons were most frequently used in the last 2 weeks (experimental arm only)
Time frame: Week 4, Week 8, Week 12, Week 16, Week 20, Week 24, Week 28, Week 32, Week 36, Week 40, Week 44, Week 48
Intervention component usage: oil dispenser
Monthly questionnaire asking about types of meals in which the oil dispenser was most frequently used in the last 2 weeks (experimental arm only)
Time frame: Week 4, Week 8, Week 12, Week 16, Week 20, Week 24, Week 28, Week 32, Week 36, Week 40, Week 44, Week 48
Intervention component usage: intervention guide
Monthly questionnaire asking about guide sections most frequently checked in the last 2 weeks
Time frame: Week 4, Week 8, Week 12, Week 16, Week 20, Week 24, Week 28, Week 32, Week 36, Week 40, Week 44, Week 48
Intervention component usage: Cookbook
Monthly questionnaire asking about cookbook sections most frequently checked in the last 2 weeks
Time frame: Week 4, Week 8, Week 12, Week 16, Week 20, Week 24, Week 28, Week 32, Week 36, Week 40, Week 44, Week 48
Intervention component usage: intervention app
Monthly questionnaire asking about app functions most frequently used in the last 2 weeks (experimental arm only)
Time frame: Week 4, Week 8, Week 12, Week 16, Week 20, Week 24, Week 28, Week 32, Week 36, Week 40, Week 44, Week 48
Protocol compliance on clinical investigation days
Self-constructed interview to verify participants' compliance with arrival time, physical activity and dietary requirements and any change in medication occurred prior to each clinical investigation day
Time frame: Week 0, Week 12, Week 36, Week 48
Taste detection
Taste detection thresholds for bitter, sweet, sour, and salty tastes, assessed using paper taste strips impregnated with the corresponding taste stimuli
Time frame: Week 3, Weeks 40 to 44
Barriers to Intervention Adherence
Qualitative information on barriers to adherence encountered after 6 months of intervention, and participants' proposed solutions or strategies to overcome these barriers, collected through focus group discussions (subsample only n=45)
Time frame: Weeks 21 to 24
End of Study Survey
Self-constructed interview to assess participant's overall experience with the intervention at study end (items include previous tools/methods employed, satisfaction with intervention, consistency of use, barriers experienced and intention to continue using the components)
Time frame: Week 48
Adverse Events
Adverse events are defined as any new unfavourable and unintended event that the participant has experienced during the course of the intervention or treatment. AE do not necessarily have a causal relationship with the intervention. Examples of AE may include: * Abnormal laboratory findings * Symptoms (e.g. gastro-intestinal discomfort, headache) * Disease * Worsening of existing symptoms Serious adverse events (SAE) are defined as any untoward medical occurrence that: * Results in death * Is life-threatening at the time of the event * Requires in-patient hospitalization as in extension of an already planned hospitalization or requiring a new (unplanned) hospitalization * Results in persistent or significant disability or incapacity * Is another important medical event
Time frame: Week 6, Week 9, Week 12, Week 16, Week 20, Week 24, Week 28, Week 32, Week 36, Week 48, plus spontaneous contacts from participants
Eating habits: Hunger levels
Fasting scores for hunger measured on a 100 mm visual analogue scale, taken before consumption of yogurt with granola (validated questionnaire based on Hill \& Blundell, 1982)
Time frame: Week 0, Week 12, Week 36, Week 48
Eating habits: Fullness levels
Fasting scores for fullness measured on a 100 mm visual analogue scale, taken before consumption of yogurt with granola (validated questionnaire based on Hill \& Blundell, 1982)
Time frame: Week 0, Week 12, Week 36, Week 48
Eating habits: Thirst levels
Fasting scores for thirst measured on a 100 mm visual analogue scale, taken before consumption of yogurt with granola (validated questionnaire based on Hill \& Blundell, 1982)
Time frame: Week 0, Week 12, Week 36, Week 48
Eating habits: Desire to eat levels
Fasting scores for desire to eat measured on a 100 mm visual analogue scale, taken before consumption of yogurt with granola (validated questionnaire based on Hill \& Blundell, 1982)
Time frame: Week 0, Week 12, Week 36, Week 48
Eating habits: Prospective intake levels
Fasting scores for prospective intake measured on a 100 mm visual analogue scale, taken before consumption of yogurt with granola (validated questionnaire based on Hill \& Blundell, 1982)
Time frame: Week 0, Week 12, Week 36, Week 48
Eating habits: Nausea levels
Fasting scores for nausea measured on a 100 mm visual analogue scale, taken before consumption of yogurt with granola (validated questionnaire based on Hill \& Blundell, 1982)
Time frame: Week 0, Week 12, Week 36, Week 48
Socio-demographic profile: Age
Age will be recorded in self-reported age in years at recruitment point
Time frame: Week -1
Socio-demographic profile: Sex
Sex will be recorded as self-reported sex assigned at birth (male, female)
Time frame: Week -1
Socio-demographic profile: Gender
Gender will be recorded as self-identified gender with one of these options: man, women, other (describe if you wish), prefer not to say.
Time frame: Week -1
Socio-demographic profile: Education
Education will be recorded as self-reported maximum education level achieved with one these options: without education; prmary education; secondary education; seconary vocational education; high vocational education; university degree; other (specify).
Time frame: Week -1
Socio-demographic profile: marital status
Marital status will be recorded as self-reported status with one of these options: married, civil union, separated, divorced, widowed, single (never married), other (specify).
Time frame: Week -1
Socio-demographic profile: Country of birth
Self-reported country of birth will be recorded using an open-ended question "country of birth"
Time frame: Week -1
Socio-demographic profile: Employment
Employment will be recorded as self-reported professional situation with one of these open-ended questions: Current job (if you have); Last job (in case of retirement, permanent leave, unemployment, etc.); Without a current or past job
Time frame: Week -1
Socio-demographic profile: Smoking status
Smoking status will be recorded as self-reported habits with one of these options: never smoked; ex-smoker (for more than 3 months); current smoker; occasional smoker (fewer than 4 cigarettes per month).
Time frame: Week -1
Socio-demographic profile: alcohol intake
Alcohol intake will be recorded as self-reported weekly alcohol unit consumption (1 unit = can, glass or shot).
Time frame: Week -1
Plan to share: Undecided
Start is estimated for Oct 2026; primary completion for Jan 2028, 15 months later.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Clinica Universidad de Navarra, Universidad de Navarra →